232
Participants
Start Date
June 1, 2013
Primary Completion Date
August 30, 2015
Study Completion Date
December 30, 2015
Oxycodone/Naloxone
Oxycodone
Beijing Hospital, Beijing
307th hospital of Chinese People's medical sciences, Beijing
Beijing Cancer Hospital, Beijing
Peking University Third Hospital, Beijing
General Hospital of Beijing Military, Beijing
Pejing Union Medical College Hospital, Beijing
Hebei Medical University Fouth Hospital, Shijiazhuang
The First Hospital of China Medical University, Shenyang
The second affiliated hospital of Dalian Medical university, Dalian
Shanghai Changzheng Hospital, Shanghai
The first people's hospital of shanghai, Shanghai
The sixth hospital of shanghai, Shanghai
Jiangsu Cancer hospital, Nanjing
The central Hospital of Jinan, Jinan
Tianjin Cancer Hospital, Tianjin
The second hospital of Nanjing Medical university, Nanjing
Sir Run Run Shaw Hospital, Hangzhou
Fuzhou General Hospital of Nanjing Military Command of PLA, Fuzhou
Tongji Hospital Tongji Medical College of HUST, Wuhan
Hubei Cancer Hospital, Changsha
The First Affiliated Hospital of Xinxiang Medical University, Xinxiang
Sun yat-sen univercity cancer center, Guangzhou
Tangdu Hospital,Fourth Military Medical University, Xi’an
Fujian Medical University Union Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
Harbin Cancer Hospital, Harbin
Jilin Cancer Hospital, Changchun
Beijing Friendship Hospital, Beijing
Mundipharma (China) Pharmaceutical Co. Ltd
INDUSTRY